Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More
U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07712588) titled 'Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TA... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More
U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07709923) titled 'Predictive Model For Anastomotic Leakage After Colorectal Cancer Surgery' on July 08. Brie... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More
U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711886) titled 'Understanding Vision Problems Linked to the Brain and Nerves in People Seen at Our Eye Clin... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More
U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711002) titled 'Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously ... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More